SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-067418
Filing Date
2014-11-13
Accepted
2014-11-13 07:44:03
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v392249_10q.htm 10-Q 449779
2 EXHIBIT 31.1 v392249_ex31-1.htm EX-31.1 12095
3 EXHIBIT 31.2 v392249_ex31-2.htm EX-31.2 11408
4 EXHIBIT 32.1 v392249_ex32-1.htm EX-32.1 4914
5 EXHIBIT 32.2 v392249_ex32-2.htm EX-32.2 4833
  Complete submission text file 0001144204-14-067418.txt   6304668

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aker-20140930.xml EX-101.INS 1099998
7 XBRL TAXONOMY EXTENSION SCHEMA aker-20140930.xsd EX-101.SCH 50053
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aker-20140930_cal.xml EX-101.CAL 47825
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aker-20140930_def.xml EX-101.DEF 261142
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aker-20140930_lab.xml EX-101.LAB 346445
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aker-20140930_pre.xml EX-101.PRE 327460
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences Inc (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-36268 | Film No.: 141216312
SIC: 2835 In Vitro & In Vivo Diagnostic Substances